Travere Therapeutics (NASDAQ:TVTX) Rating Increased to Neutral at Bryan, Garnier & Co

Bryan, Garnier & Co upgraded shares of Travere Therapeutics (NASDAQ:TVTX – Get Rating) from a sell rating to a neutral rating in a research report released on Friday, Briefing.com reports. Several other research firms have also issued reports on TVTX. Piper Sandler lowered their target price on shares of Travere Therapeutics from $44.00 to $41.00 […]

Related Keywords

San Diego ,California ,United States ,New York ,Piper Sandler ,Zurcher Kantonalbank Zurich Cantonalbank ,Barclays ,Mirae Asset Global Investments Co ,York Life Investment Management ,Travere Therapeutics Inc ,Canaccord Genuity Group ,Barclays Plc ,Monashee Investment Management ,Garnier Co ,Travere Therapeutics ,Get Rating ,Genuity Group ,Moderate Buy ,Kantonalbank Zurich Cantonalbank ,Investment Management ,Mirae Asset Global Investments ,Asset Global Investments ,Martin Shkreli ,Travere Therapeutics Daily ,Nasdaq Tvtx ,Tvtx ,Medical ,Upgrade ,Bryan Garnier Co ,